(131)I-labeled anti-CD33 ((131)I-M195) may prolong disease-free survival (DFS) in relapsed acute promyelocytic leukemia (APL) after remission induction with all-trans retinoic acid (RA) Meeting Abstract


Authors: Jurcic, J. G.; Caron, P. C.; Miller, W. H. Jr; Yao, T. J.; Maslak, P.; Finn, R.; Larson, S. M.; Warrell, R. P. Jr; Scheinberg, D. A.
Abstract Title: (131)I-labeled anti-CD33 ((131)I-M195) may prolong disease-free survival (DFS) in relapsed acute promyelocytic leukemia (APL) after remission induction with all-trans retinoic acid (RA)
Meeting Title: 35th Annual Meeting of the American Society of Hematology
Journal Title: Blood
Volume: 82
Issue: 10 Suppl. 1
Meeting Dates: 1993 Dec 3-7
Meeting Location: St. Louis, MO
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 1993-11-15
Start Page: 193a
Language: English
ACCESSION: WOS:A1993MJ68200755
PROVIDER: wos
PUBMED: 8219212
Notes: Meeting Abstract: 756 -- Source: Wos
Citation Impact
MSK Authors
  1. Tzy-Jyun Yao
    59 Yao
  2. Ronald D Finn
    279 Finn
  3. Joseph G Jurcic
    134 Jurcic
  4. Peter Maslak
    197 Maslak
  5. Steven M Larson
    958 Larson
  6. Philip C Caron
    90 Caron
  7. Raymond P Warrell
    175 Warrell
  8. Wilson H. Miller Jr
    48 Miller
Related MSK Work